
OpenAI Moves into Drug Discovery via Orchestra Bio Acquisition
The deal aims to integrate AI tools into the operational workflow of bio-R&D.
Daily archive

The deal aims to integrate AI tools into the operational workflow of bio-R&D.

Nacha data shows usage expanding in volume and value as companies continue moving away from checks.

The service aggregates payment signals and blockchain analytics before and after funds move.

The AI-powered assistant displays the right benefit within the issuing bank's channel.

The concept shifts the debate from an agent's ability to pay to the identity of the delegator and spending limits.

The collaboration targets trial selection, safety monitoring, and integrating evidence into clinical workflows.